Synergistic interaction of platelet derived growth factor (PDGF) with the surface of PLLA/Col/HA and PLLA/HA scaffolds produces rapid osteogenic differentiation

Colloids Surf B Biointerfaces. 2016 Mar 1:139:68-78. doi: 10.1016/j.colsurfb.2015.11.053. Epub 2015 Nov 28.

Abstract

Scaffolds with structural features similar to the extracellular matrix stimulate rapid osteogenic differentiation in favorable microenvironment and with growth factor supplementation. In this study, the osteogenic potential of electrospun poly-l-lactide/hydroxyapatite/collagen (PLLA/Col/HA, PLLA/HA and PLLA/Col) scaffolds were tested in vitro with the supplementation of platelet derived growth factor-BB (PDGF-BB). Cell attachment and topography, mineralization, extracellular matrix protein localization, and gene expression of the human mesenchymal stromal cells were compared between the fibrous scaffolds PLLA/Col/HA, PLLA/Col, and PLLA/HA. The levels of osteocalcin, calcium, and mineralization were significantly greater in the PLLA/Col/HA and PLLA/HA compared with PLLA/Col. High expression of fibronectin, intracellular adhesion molecule, cadherin, and collagen 1 (Col1) suggests that PLLA/Col/HA and PLLA/HA scaffolds had superior osteoinductivity than PLLA/Col. Additionally, osteopontin, osteocalcin, osterix, Runt-related transcription factor 2 (Runx2), and bone morphogenic protein (BMP2) expression were higher in PLLA/Col/HA and PLLA/HA compared with PLLA/Col. In comparison with PLLA/Col, the PLLA/Col/HA and PLLA/HA scaffolds presented a significant upregulation of the genes Runx2, Col 1, Integrin, osteonectin (ON), bone gamma-carboxyglutamic acid-containing protein (BGALP), osteopontin (OPN), and BMP2. The upregulation of these genes was further increased with PDGF-BB supplementation. These results show that PDGF-BB acts synergistically with PLLA/Col/HA and PLLA/HA to enhance the osteogenic differentiation potential. Therefore, this combination can be used for the rapid expansion of bone marrow stromal cells into bone-forming cells for tissue engineering.

Keywords: Bone marrow; Electrospinning; Osteoblast; Osteocalcin; Scaffold.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Becaplermin
  • Biomarkers / metabolism
  • Bone Marrow Cells / cytology
  • Bone Marrow Cells / drug effects
  • Bone Marrow Cells / metabolism
  • Bone Morphogenetic Protein 2 / genetics
  • Bone Morphogenetic Protein 2 / metabolism
  • Calcification, Physiologic / drug effects
  • Cell Differentiation / drug effects
  • Collagen Type I / genetics
  • Collagen Type I / metabolism
  • Collagen Type I / pharmacology*
  • Core Binding Factor Alpha 1 Subunit / genetics
  • Core Binding Factor Alpha 1 Subunit / metabolism
  • Durapatite / chemistry
  • Durapatite / pharmacology*
  • Fibronectins / genetics
  • Fibronectins / metabolism
  • Gene Expression
  • Humans
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / drug effects*
  • Mesenchymal Stem Cells / metabolism
  • Osteoblasts / cytology
  • Osteoblasts / drug effects*
  • Osteoblasts / metabolism
  • Osteocalcin / genetics
  • Osteocalcin / metabolism
  • Osteogenesis / drug effects
  • Osteopontin / genetics
  • Osteopontin / metabolism
  • Polyesters / chemistry
  • Polyesters / pharmacology*
  • Primary Cell Culture
  • Proto-Oncogene Proteins c-sis / pharmacology*
  • Sp7 Transcription Factor
  • Tissue Engineering
  • Tissue Scaffolds
  • Transcription Factors / genetics
  • Transcription Factors / metabolism

Substances

  • BMP2 protein, human
  • Biomarkers
  • Bone Morphogenetic Protein 2
  • Collagen Type I
  • Core Binding Factor Alpha 1 Subunit
  • Fibronectins
  • Polyesters
  • Proto-Oncogene Proteins c-sis
  • RUNX2 protein, human
  • Sp7 Transcription Factor
  • SP7 protein, human
  • Transcription Factors
  • Osteocalcin
  • Osteopontin
  • Becaplermin
  • poly(lactide)
  • Durapatite